Summary
Johnson & Johnson (JNJ) announced the completion of a significant public offering of debt securities on February 20, 2025. The company successfully issued a total of $5.25 billion in notes across various maturities ranging from 2027 to 2035. This capital raise includes $750 million in 4.500% Notes due 2027, $750 million in 4.550% Notes due 2028, $1 billion in 4.700% Notes due 2030, $1.25 billion in 4.850% Notes due 2032, and $1.25 billion in 5.000% Notes due 2035. The offering was conducted under the company's existing shelf registration statement.
Key Highlights
- 1JNJ completed a $5.25 billion debt offering on February 20, 2025.
- 2The offering consisted of notes with maturities between 2027 and 2035.
- 3Interest rates on the notes range from 4.500% to 5.000% annually.
- 4The company issued specific tranches of $750M (2027 & 2028), $1B (2030), and $1.25B (2032 & 2035).
- 5This offering was executed under Johnson & Johnson's Form S-3 Registration Statement.
- 6The company entered into an underwriting agreement with major financial institutions including Citigroup, BofA Securities, and J.P. Morgan.
Frequently Asked Questions
Johnson & Johnson raised a total of $5.25 billion through the issuance of various notes.
The notes issued have maturities in 2027 (4.500%), 2028 (4.550%), 2030 (4.700%), 2032 (4.850%), and 2035 (5.000%).
While the filing does not explicitly state the use of proceeds, debt offerings are typically undertaken to fund operations, capital expenditures, acquisitions, or to refinance existing debt. Investors should refer to future company communications or financial reports for specific details on the use of these funds.
The offering was underwritten by Citigroup Global Markets Inc., BofA Securities, Inc., and J.P. Morgan Securities LLC, acting as representatives for the several Underwriters.